Publications

Lessons from running a neurology strategic clincial network.
Losseff N
Advances in Clinical Neuroscience and Rehabilitation- 2017;16:20-24

Challenging Hunt on strokes.
Collaborative authors
Sunday Times - letters Jan 17 2016.

Cerebral involvement in IgG4-related disease.

Joshi D, Jager R, Hurel S, Pereira SP, Johnson GJ, Chapman M, Fowler R, Winstanley A, Losseff N, Webster GJ. 
Clinical Medicine. 2015:130-4.


Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy.
Mantoan Ritter L, Schüler A, Gangopadhyay R, Mordecai L, Arowele O, Losseff N,
O' Brien P, Dewan B.
Journal of Neurology. 2014;261:632-4.


Can cerebral microbleeds cause an acute stroke syndrome?
Teo JT, Ramadan H, Gregoire SM, Mufti S, Lipman G H. Jager RH, Losseff NA, and Werring D
Neurology Clinical Practice 2011;1 75-77.


Cerebral venous sinus thrombosis may be associated with clozapine. 
Werring D, Hacking D, Losseff N, Jäger HR, Walsh M, Foong J.
J Neuropsychiatry Clin Neurosci. 2009; 21:343-5. 


Priorities in stroke care. The London stroke strategy.
Losseff N, Ames D, Cloud G, Cluckie G, Gompertz P, Grant B, Markus H, Brown MM.
BMJ. 2009 Jun 29;338:b2616.

 The role of the thalamus in amnesia: a tractography, high-resolution MRI and neuropsychological study.
Cipolotti L, Husain M, Crinion J, Bird CM, Khan SS, Losseff N, Howard RS, Leff AP.
Neuropsychologia. 2008 Sep;46(11):2745-58. 

Neurological picture. Varicella zoster virus and intracranial dolichoectasia in a late adult cancer survivor.
Dalton CM, Jäger HR, Losseff NA, Greenwood RJ.
J Neurol Neurosurg Psychiatry. 2008 May;79(5):573. 


Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.
Sheerin UM, Barreto J,Brown MM, Brew S, Losseff NA.
Journal of Neurology. 2008 Apr;255(4):607-8. 


Haematology and neurology.
Austin S, Cohen H, Losseff N.
J Neurol Neurosurg Psychiatry. 2007 Apr;78(4):334-41. 
Free PMC article

Cerebral microbleeds are common in ischemic stroke but rare in TIA.
Werring DJ, Coward LJ, Losseff NA, Jäger HR, Brown MM.
Neurology. 2005 Dec 27;65(12):1914-8.
Greenwood RJ, Strens LH, Watkin J, Losseff N, Brown MM.
Br J Neurosurg. 2004 Oct;18(5):462-6.
 

A case of restless legs syndrome in association with stroke.
Anderson KN, Bhatia KP, Losseff NA.
Sleep. 2005 Jan 1;28(1):147-8. 

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.
Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, Brown MM, Jäger HR.
Brain. 2004 Oct;127(Pt 10):2265-75. Free Article

Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis.
Furrows SJ, Hartley JC, Bell J, Silver N, Losseff N, Stevenson S, Chapman M, Thompson EJ, Ridgway GL, Giovannoni G.
J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):152-4.
Free PMC article

Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity.
Garrard P, Bradshaw D, Jäger HR, Thompson AJ, Losseff N, Playford D.
J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):191-4. Free PMC article

Shortening inpatient stay for stroke.
Edwards SG, Thompson AJ, Losseff N, Playford ED.
Lancet. 2002 Jun 22;359(9324):2205.


T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study.
Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, Miller DH.
Eur J Neurol. 2001 Jan;8(1):37-42.


T1 hypointensity of the spinal cord in multiple sclerosis.
Losseff NA, Wang L, Miller DH, Thompson AJ.
J Neurol. 2001 Jun;248(6):517-21.

 
Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis.
Giovannoni G, Miller DH, Losseff NA, Sailer M, Lewellyn-Smith N, Thompson AJ, Thompson EJ.
J Neurol. 2001 Jun;248(6):487-95.

 
The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis--preliminary results.
Losseff NA, Miller DH, Kidd D, Thompson AJ.
Mult Scler. 2001 Feb;7(1):23-5.

 
The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.
Molyneux PD, Kappos L, Polman C, Pozzilli C, Barkhof F, Filippi M, Yousry T, Hahn D, Wagner K, Ghazi M, Beckmann K, Dahlke F, Losseff N, Barker GJ, Thompson AJ, Miller DH.
Brain. 2000 Nov;123 ( Pt 11):2256-63. Free Article

 
MRI of the intraorbital optic nerve in patients with autosomal dominant optic atrophy.
Votruba M, Leary S, Losseff N, Bhattacharya SS, Moore AT, Miller DH, Moseley IF.
Neuroradiology. 2000 Mar;42(3):180-3.
Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, Harvey RJ, Rossor MN, Miller DH, Thompson AJ.
Neurology. 2000 Feb 22;54(4):807-12.
Mathias JM, Tofts PS, Losseff NA.
Magn Reson Med. 1999 Nov;42(5):929-35.
Stevenson VL, Leary SM, Losseff NA, Parker GJ, Barker GJ, Husmani Y, Miller DH, Thompson AJ.
Neurology. 1998 Jul;51(1):234-8. Free Article
Losseff NA, Miller DH
J Neurol Neurosurg Psychiatry. 1998 May;64 Suppl 1:S102-5

 
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination.
O'Riordan JI, Losseff NA, Phatouros C, Thompson AJ, Moseley IF, MacManus DG, McDonald WI, Miller DH.
J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):353-7.
Free PMC article
Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Adèr HJ, Losseff N, Valk J.
Brain. 1997 Nov;120 ( Pt 11):2059-69. Free Article
 
Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis.
Silver NC, Barker GJ, Losseff NA, Gawne-Cain ML, MacManus DG, Thompson AJ, Miller DH.
Neuroradiology. 1997 Jun;39(6):441-5.
Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, Miller DH, Thompson AJ.
Brain. 1996 Dec;119 ( Pt 6):2009-19. Free Article

 
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.
Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ.
Brain. 1996 Jun;119 ( Pt 3):701-8 Free Article

 
Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis.
Losseff NA, Kingsley DP, McDonald WI, Miller DH, Thompson AJ.
Mult Scler. 1996 Feb;1(4):218-22


Manifestations of central nervous system involvement in Guillain—Barré syndrome: clinical, MRI and EEG findings.
Losseff, N.A., Miller, D.H., Fletcher, N., Hirsch, N.P., Thorpe, J.W. and Howard, R.S., 1
European Journal of Neurology. 1996 3(5), p480.


The benefit of inpatient neurorehabilitation in multiple sclerosis.
Kidd D, Howard RS, Losseff NA, Thompson AJ.
Clinical Rehabilitation. 1995 (9):198-203


The medical management of increased tone.
Losseff NA, Thompson AJ.
Physiotherapy. 1995 (81):480-84
Thorpe JW, Barker GJ, Jones SJ, Moseley I, Losseff N, MacManus DG, Webb S, Mortimer C, Plummer DL, Tofts PS, et al.
J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):487-92.
Free PMC article

 
Management of mitochondrial disease on an intensive care unit.
Howard RS, Russell S, Losseff N, Harding AE, Hughes JM, Wiles CM, Miller DH, Hirsch NP.
QJM. 1995 Mar;88(3):197-207


Primary CNS lymphoma.
Losseff N, Palace J.
Br J Hosp Med. 1993 Dec 15-1994 Jan 18;50(11):678-9.
 

Isolated dysphagia due to polymyositis.
Palace J, Losseff N, Clough C.
Muscle Nerve. 1993 Jun;16(6):680-1. 
© Copyright 2017 Nick LosseffWeb Design By Toolkit Websites